Swiss Life Sciences Stock News

DKSH Holding (SWX:DKSH) is back in focus after its Malaysian unit reported a 34.8% year-on-year jump in second quarter net profit, supported by higher revenue and unrealised foreign exchange gains. See our latest analysis for DKSH Holding. At a share price of CHF66.40, DKSH Holding has seen its 30 day share price return of 3.75% and year to date share price return of 13.31%. The 1 year total shareholder return is 19.71%, which suggests momentum has been building rather than fading...

Sika (SWX:SIKA) has drawn fresh investor attention after issuing €1b in hybrid capital bonds split into two callable, subordinated tranches, while S&P shifted its issuer rating outlook on the company from Negative to Stable. See our latest analysis for Sika. For investors, the hybrid bond issuance and S&P outlook revision arrive as Sika’s share price shows renewed momentum, with a 30-day share price return of 17.92% and a 90-day gain of 25.14%, even though the 5-year total shareholder return...

Cosmo (SWX:CMHC) is back in focus after reporting 12 month Phase 3 data for its clascoterone 5% topical solution in male pattern hair loss, highlighting sustained efficacy and a safety profile comparable to vehicle. See our latest analysis for Cosmo. Despite the latest clascoterone update putting Cosmo back on investors’ radar, the stock has seen its share price fall 9.35% over the past month and 25.48% over the past quarter. At the same time, the 1 year total shareholder return of 7.43% and...

Landis+Gyr Group (SWX:LAND) recently expanded its Edge Application Ecosystem in Australia by adding Future Grid and Operational Technology Solutions as partners. For investors, this product move raises fresh questions about the stock’s positioning. See our latest analysis for Landis+Gyr Group. The Edge App Ecosystem update arrives after a mixed period for Landis+Gyr Group, with the share price at CHF46.85, a 30 day share price return of 6.96% but a year to date share price return that is down...

Why Basilea Pharmaceutica stock is back in focus Basilea Pharmaceutica (SWX:BSLN) is drawing fresh attention after reporting CHF 119 million in first half 2026 revenue and CHF 27.95 million in net income, along with higher full year guidance for both total revenue and operating profit. See our latest analysis for Basilea Pharmaceutica. The latest earnings and raised guidance have been met with a sharp shift in sentiment. Basilea Pharmaceutica’s share price return is 23.1% over 90 days and the...

Novavest Real Estate stock closed at CHF39.00 on 20 August, roughly flat over the past week and down over the last quarter, even as the latest half year numbers landed with very strong profitability. The headline is the margin story. Net profit margin over the past twelve months reached 76%, supported by a CHF9.5m one off gain that lifts the optics of earnings far above the underlying trend. For you as an investor, this is a classic time horizon test. The short term readout looks impressive...

Banque Cantonale Vaudoise came into this earnings day priced for perfection, trading on a rich 24.3x P/E and carrying a 3.62% dividend yield, yet the stock has drifted over the past month. The headline today is that profitability is being gently squeezed. Trailing net profit margin sits at 37.4%, slightly lower than the prior year, while risk weighted assets are climbing in step with mortgage and loan growth. For a bank already valued above Swiss and European peers, this margin pressure is...

Last week saw the newest half-yearly earnings release from PSP Swiss Property AG ( VTX:PSPN ), an important milestone...

Barclays is once again reshaping its investment bank, cutting leadership, tightening capital and leaning harder on its markets division. That shift could leave more room for UK and European retail and wealth focused banks that rely on simpler deposit and lending models rather than capital intensive trading and dealmaking. This article walks through three stocks exposed to that story and explains how the recent shake up might matter for your portfolio decisions. The three stocks covered below...

Banque Cantonale Vaudoise (SWX:BCVN) reported half year earnings to June 30, 2026, with net interest income of CHF 264.9 million and net income of CHF 225 million. This information can reshape how investors assess the stock. See our latest analysis for Banque Cantonale Vaudoise. The latest half year results arrive after a mixed few weeks in the market for Banque Cantonale Vaudoise, with the share price down 4.9% over the past month but still showing a 17.6% year to date share price return and...

Elma Electronic stock closed at CHF1,320 on Thursday, barely moved over the past week, while the latest earnings tell a much harsher story. The company booked a loss of CHF1.8 million for the first half of 2026 on revenue of CHF77.7 million, turning recent profit into red ink. In the short term, that profit squeeze and weak interest coverage frame the risk. Over a multi year lens, the bigger question is how long investors will keep paying about 1.9x sales for an unprofitable industrial...

Schindler Holding wins high profile New York modernization contract Schindler Holding (SWX:SCHN) has secured the modernization of 31 elevators at the General Motors Building in Midtown Manhattan, a high profile project that features its PORT destination system in a heavily trafficked office tower. See our latest analysis for Schindler Holding. The GM Building contract comes at a time when Schindler Holding’s share price has shown a 3.69% gain over the past month, while its year-to-date share...

UBS Group stock has already delivered a 217.1% total return over the past 5 years, yet the current share price around US$42.72 still screens as undervalued when compared with an intrinsic value estimate based on the Excess Returns model and with standard market multiples. A 217.1% return over 5 years suggests UBS Group has already rewarded long term shareholders while raising the bar for what counts as further upside from here. Future profitability and capital returns can support the current...

Liechtensteinische Landesbank stock came into this earnings print near CHF114 after a steady 12 month climb, with investors already paying a premium P/E for what they viewed as dependable profitability. The latest half year numbers kept that story intact. Net income reached about CHF105m on CHF315m of revenue, indicating a high net margin profile and reflecting the recent 7.4% earnings growth pace over the past year. The twist is in sentiment. A market that has been willing to pay up for...

St. Galler Kantonalbank (SWX:SGKN) reported its half year 2026 results with net interest income of CHF 190.17 million and net income of CHF 119.87 million, compared with CHF 184.92 million and CHF 114.1 million a year earlier. See our latest analysis for St. Galler Kantonalbank. St. Galler Kantonalbank’s recent half year 2026 earnings release comes after a steady share price gain, with the year to date share price return of 8.5% and a 1 year total shareholder return of 30.13%, suggesting...

Galenica AG recently reported past half-year 2026 results, with sales rising to CHF 2,136.45 million and revenue to CHF 2,143.28 million, while net income decreased to CHF 66.35 million and earnings per share eased compared with the prior year period. Despite the softer profitability, management confirmed its 2026 outlook for consolidated net sales growth of 5.7% and EBIT growth between 6% and 8%, underscoring confidence in the business trajectory. With Galenica confirming its 2026 earnings...

Market reaction to mixed half year performance Huber+Suhner (SWX:HUBN) reported half year 2026 results with sales at CHF 457.4 million and net income at CHF 34.75 million. Earnings per share were CHF 1.88, with sales higher and profit measures softer compared with the previous year. See our latest analysis for Huber+Suhner. Since the latest half year results on 14 August 2026, Huber+Suhner’s share price has been under pressure, with a 7 day share price return down 15.17% and 90 day share...

SGS (SWX:SGSN) is in focus after Allonnia launched a centralized pilot program at SGS's Lakefield facility, giving mining companies a simpler path to test D-Solve biological impurity removal technology. See our latest analysis for SGS. At a share price of CHF93.2, SGS has seen a 6.51% 90 day share price return and a 14.46% 1 year total shareholder return, which points to gradually improving momentum around the stock despite recent short term softness. If this kind of specialty metals and...

Half year earnings put Berner Kantonalbank stock in focus Berner Kantonalbank (SWX:BEKN) is back on investors’ radar after half year 2026 earnings showed net income of CHF 82.65 million on net interest income of CHF 191.82 million, prompting fresh attention on the stock’s recent performance. See our latest analysis for Berner Kantonalbank. The half year earnings update appears to have arrived during a strong run for Berner Kantonalbank, with the share price at CHF 380.50 and a year to date...

Sunrise Communications stock came into today looking bruised, with the share price drifting down roughly 3% over the past month and about 3% over the last quarter. The long term pitch around a cheap telecom with a turnaround story met some hard numbers in the latest release. Revenue for the last twelve months sat at CHF 2.98b while the company still reported a loss from continuing operations and negative earnings per share. The real headline is not growth but pressure. Profitability remains...

Implenia stock closed at CHF67.60, capping a strong 90 day run, yet the real story sits in the pressure on profitability. The construction and engineering group is still producing earnings and cash flows that keep the shares on a P/E of 14.9x, below both the European sector and peers, but net profit margins have tightened. For short term traders the recent share price strength may feel reassuring. Long term holders will focus more on whether management can protect margins while pursuing...

HIAG Immobilien Holding (SWX:HIAG) has drawn investor focus after reporting half year 2026 results that include CHF 158.63 million in revenue and CHF 84.97 million in net income, alongside higher earnings per share. See our latest analysis for HIAG Immobilien Holding. Alongside these half year results and fresh CHF 100 million green bond issuance, HIAG Immobilien Holding has seen mixed momentum, with the share price up 7.01% year to date but down 8.35% over 30 days, while the 1 year total...

DocMorris stock closed at CHF10.00 on the day of its latest earnings, capping a volatile few months that included a sharp rebound over the past quarter. The market has been treating DocMorris as a high growth, online pharmacy bet. The headline from the latest numbers is more sobering. Revenue over the last twelve months reached about CHF1.1b, yet the company still reported a sizeable loss from continuing operations and a loss per share in the mid single digit CHF range. The expectation gap is...

Emmi stock closed at CHF830 on the day of its earnings release, capping a choppy spell that left the shares down about 4% over the past week and 7% over the past month. The market is clearly wary. The results themselves point to a different tension. Earnings over the last twelve months grew faster than the company’s own five year trend; however, the net profit margin edged down to 4.8% from 5.1%, and investors still have to weigh that against a high debt load. Like the earnings growth at Emmi...